Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03075696 |
|---|---|
| Brief Title: | A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma |
| First Submitted : | March 7, 2017 |
| First Submitted that Met QC Criteria : | March 7, 2017 |
| First Posted : | March 9, 2017 |
| Last Update Submitted that Met QC Criteria : | May 13, 2024 |
| Last Update Posted : | May 14, 2024 |